Skip to Accessibility Tools Skip to Content Skip to Footer


Biosimilar Update

This past year, the FDA approved three biosimilars for use in rheumatology. A biosimilar to Remicade, called Inflectra, launched in late

World Arthritis Day

Awareness campaigns like Breast Cancer Awareness Month (which is actually right now in October), Pancreatic Cancer Awareness Month, and Food